Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | PI4KA | P42356 | 1/20 | 0.33 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.33 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.33 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.32 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26829262 | 0.90 | POLRMT (0.36) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL24606260 | 0.89 | POLRMT (0.37) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL26237706 | 0.87 | POLRMT (0.35) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL26237940 | 0.86 | POLRMT (0.34) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL16708543 | 0.84 | POLRMT (0.37) | POLRMTRXFP1P2RX1P2RX3P2RX4 | |
| SCHEMBL26212426 | 0.83 | POLRMT (0.33) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL13532207 | 0.83 | PI4KA (0.47) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL16710454 | 0.83 | PI4KA (0.47) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL25919452 | 0.82 | POLRMT (0.34) | POLRMTALDH1A1RXFP1P2RX1P2RX3 | |
| SCHEMBL15605903 | 0.82 | POLRMT (0.37) | POLRMTRXFP1P2RX1P2RX3P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. | 2023-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | EIF2AK2, MAVS, ZC3HAV1 | POLRMT 13/4885ALDH1A1 3135/4885RXFP1 4653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.